These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22912668)

  • 1. Performance of the PointCare NOW system for CD4 counting in HIV patients based on five independent evaluations.
    Bergeron M; Daneau G; Ding T; Sitoe NE; Westerman LE; Stokx J; Jani IV; Coetzee LM; Scott L; De Weggheleire A; Boel L; Stevens WS; Glencross DK; Peter TF
    PLoS One; 2012; 7(8):e41166. PubMed ID: 22912668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women.
    Myer L; Daskilewicz K; McIntyre J; Bekker LG
    J Int AIDS Soc; 2013 Sep; 16(1):18649. PubMed ID: 24044627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the FACSPresto, a New Point of Care Device for the Enumeration of CD4% and Absolute CD4+ T Cell Counts in HIV Infection.
    Makadzange AT; Bogezi C; Boyd K; Gumbo A; Mukura D; Matubu A; Ndhlovu CE
    PLoS One; 2016; 11(7):e0157546. PubMed ID: 27388763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near patient CD4 count in a hospitalized HIV patient population.
    Givens M; Weaver A; Bickman S; Logan C; Noormahomed EV; Patel S; Schooley RT; Benson CA; Lochhead MJ
    Cytometry B Clin Cytom; 2017 Nov; 92(6):451-455. PubMed ID: 25917935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 results with a bias larger than hundred cells per microliter can have a significant impact on the clinical decision during treatment initiation of HIV patients.
    Daneau G; Buyze J; Wade D; Diaw PA; Dieye TN; Sopheak T; Florence E; Lynen L; Kestens L
    Cytometry B Clin Cytom; 2017 Nov; 92(6):476-484. PubMed ID: 26917223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical performance evaluation of the MyT4 point of care technology for CD4+ T cell enumeration.
    Mwau M; Kadima S; Mwende J; Adhiambo M; Akinyi C; Prescott M; Lusike J; Hungu J; Vojnov L
    PLoS One; 2014; 9(9):e107410. PubMed ID: 25229408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the BD FACSPresto near to patient analyzer in comparison with representative conventional CD4 instruments in Cameroon.
    Sagnia B; Mbakop Ghomsi F; Gutierrez A; Sosso S; Kamgaing R; Nanfack AJ; Nji N; Ambada G; Lissom A; Tchouangueu TF; Ngu Ndengkoh L; Domkam I; Nchinda G; Ndjolo A
    AIDS Res Ther; 2020 Aug; 17(1):53. PubMed ID: 32799909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of two POC technologies for CD4 count in Morocco.
    Elharti E; Abbadi H; Bensghir R; Marhoum El Filali K; Elmrabet H; Oumzil H
    AIDS Res Ther; 2020 Jun; 17(1):31. PubMed ID: 32522235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory and field evaluation of the Partec CyFlow miniPOC for absolute and relative CD4 T-cell enumeration.
    Wade D; Diaw PA; Daneau G; Diallo AA; Mboup S; Dieye TN; Kestens L
    PLoS One; 2015; 10(2):e0116663. PubMed ID: 25688553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy.
    Mnyani CN; McIntyre JA; Myer L
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):260-4. PubMed ID: 22487589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4-T cell enumeration in human immunodeficiency virus (HIV)-infected patients: A laboratory performance evaluation of Muse Auto CD4/CD4% system by World Health Organization prequalification of in vitro diagnostics.
    Ceulemans A; Bouzahzah C; Prat I; Urassa W; Kestens L
    PLoS One; 2019; 14(1):e0209677. PubMed ID: 30673713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New BD FACSCount CD4 reagent system for simultaneous enumeration of percent and absolute CD4 T-lymphocytes in HIV-1-infected pediatric patients.
    Pattanapanyasat K; Sukapirom K; Kowawisatsut L; Thepthai C
    Cytometry B Clin Cytom; 2008; 74 Suppl 1():S98-106. PubMed ID: 18307252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a flow cytometry method for CD4 T cell enumeration based on volumetric primary CD4 gating using thermoresistant reagents.
    Dieye TN; Diaw PA; Daneau G; Wade D; Sylla Niang M; Camara M; Diallo AA; Toure Kane C; Diop Ndiaye H; Mbengue B; Dieye A; Kestens L; Mboup S
    J Immunol Methods; 2011 Sep; 372(1-2):7-13. PubMed ID: 21835181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapy.
    Peeling RW; Sollis KA; Glover S; Crowe SM; Landay AL; Cheng B; Barnett D; Denny TN; Spira TJ; Stevens WS; Crowley S; Essajee S; Vitoria M; Ford N
    PLoS One; 2015; 10(3):e0115019. PubMed ID: 25790185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new single-parameter volumetric flow cytometer (CyFlow(green)) for enumeration of absolute CD4+ T lymphocytes in human immunodeficiency virus type 1-infected Thai patients.
    Pattanapanyasat K; Lerdwana S; Noulsri E; Chaowanachan T; Wasinrapee P; Sakulploy N; Pobkeeree V; Suksripanich O; Thanprasertsuk S; Spira TJ; Tappero JW; Levine WC
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1416-24. PubMed ID: 16339065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapy.
    Manabe YC; Wang Y; Elbireer A; Auerbach B; Castelnuovo B
    PLoS One; 2012; 7(4):e34319. PubMed ID: 22536323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of point-of-care CD4 testing technologies in resource-constrained settings: a systematic review and meta-analysis.
    Pham MD; Agius PA; Romero L; McGlynn P; Anderson D; Crowe SM; Luchters S
    BMC Infect Dis; 2016 Oct; 16(1):592. PubMed ID: 27769181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance evaluation of BD FACSPresto™ point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria.
    Negedu-Momoh OR; Jegede FE; Yakubu A; Balogun O; Abdullahi M; Badru T; Oladele EA; Agbakwuru C; Khamofu H; Torpey K
    PLoS One; 2017; 12(5):e0178037. PubMed ID: 28542359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute and percent CD4+ T-cell enumeration by flow cytometry using capillary blood.
    Sitoe N; Luecke E; Tembe N; Matavele R; Cumbane V; Macassa E; Vaz P; Sheppard H; Jani IV
    J Immunol Methods; 2011 Sep; 372(1-2):1-6. PubMed ID: 21787779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4 cell count variability with repeat testing in South Africa: Should reporting include both absolute counts and ranges of plausible values?
    Daniel Francois Venter W; Chersich MF; Majam M; Akpomiemie G; Arulappan N; Moorhouse M; Mashabane N; Glencross DK
    Int J STD AIDS; 2018 Nov; 29(11):1048-1056. PubMed ID: 29749876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.